|
市場調查報告書
表觀遺傳學、多能化及再編程市場：2009年
Epigenetics, Pluripotency, and Reprogramming 2009 Market Report
|
表觀遺傳學、多能化及再編程市場：2009年 是由出版商Select Biosciences, Ltd.在2009年05月所出版的。
這份英文市場調查報告書包含139 pages 價格從美金2510起跳。
本報告書內容包括：表觀遺傳學、細胞再編程市場的最新動向分析、該市場的未來展望及市場動向之定量、定性評價等。內容綱要摘記如下：
第1章 實施概要
第2章 表觀遺傳學：分化及疾病的中心角色
- 表觀遺傳學修飾的機制及效果
- 有助於表觀遺傳學法規限制等DNA組織蛋白修飾
- 表觀遺傳學修飾如何影響基因發現的？
- 各種疾病的表觀遺傳學異常：受影響的基因
第3章 表觀遺傳學市場環境
- 表觀遺傳學治療
- HDAC抑制劑：現況及研究產品線
- DNA甲基化抑制劑：現況及研究產品線
- 表觀遺傳學治療的新興市場動向
- 全球市場的表觀遺傳學：資料及分析
- 定性市場動向
- 定量市場動向
第4章 多能化、hESC、再編程、iPSC：技術及市場環境
- iPSC：潛在用途及侷限
- 用於細胞再編程的小分子及因子
- 針對細胞再編程的因子傳遞法
- 全球市場動向：資料及分析
- 定性市場動向
- 定量市場動向
- 各種hESC線型態的利用
附錄I：調查方法
附錄II：全球hESC的法規限制環境
附錄III：表觀遺傳學治療產品線
Abstract
This is the latest and most up-to-date Epigenetics, Cellular Reprogramming,
and iPSC Market Analysis Report from Select Biosciences. This comprehensive
report provides a thorough discussion and analysis of the emerging epigenetics
space and cellular reprogramming and the iPSC phenomenon from both a technical
as well as market-focused perspective. Qualitative and quantitative analysis
of the epigenetics and pluripotency, hESC, iPSC spaces thorough bottom-up
based market trends obtained via detailed market surveys administered by
Select Biosciences to a worldwide industry participant pool are presented in
this report. All report purchasers receive access to all the raw market data
collected via online access to our secure server - allows the report
purchasers to query the data in different ways to analyze the various market
segments.
This Comprehensive Industry Report Addresses the Technical and Market
Landscape of Epigenetics, Reprogramming, and Induced Pluripotent Stem Cells
(iPSCs): These are Emerging Areas for which Qualitative and Quantitative
Analyses are presented
Extensive Worldwide Technical and Market Analyses Presented in this Report:
- Technical aspects of Epigenetics: The various modifications that
constitute epigenetics, their roles in vivo and experimental methods to detect
them
- Genes that are subject to epigenetic modifications in various disease
areas (various cancers, CNS diseases)
- Epigenetics-based therapeutics: Mechanisms of action, preclinical and
clinical trials pipelines (for DNA methylation-based therapeutics, HDAC
inhibitors)
- Commercialized epigenetics-based therapeutics
- Cellular reprogramming, pluripotency, and iPSCs: Technology trends, in
vivo mechanism, experimental manipulation, and emerging trends
- Results and Analyses from Select Biosciences recent worldwide market
surveys focusing upon the qualitative and quantitative trends in epigenetics
and pluripotency/hESCs/iPSCs. Areas of coverage include the market penetrance
of various hESCs used industry-wide, distribution of the industry with respect
to types of epigenetic modifications studied, and emerging market trends in
epigenetics and the iPSC spaces. All report purchasers also receive access to
the raw market data via online access to secure server
- More details of the scope of coverage of this industry report are found in
the table of contents (TOC) for the report - see below for link to
downloadable PDF of the TOC
Table of Contents
Description of Chapters/Topics Covered
Chapter 1 Executive Summary
- Scope of this market report
- Developmental potential and epigenetic states of cells are intricately
linked
- Pluripotency - An eppigenetic phenomenon
- Epigenetic characteristics of somatic and pluripotent cells
- Proposed mechanisms of cellular reprogramming to create iPSCs
- Summary of epigenetic modifications and their effects
- Summary of technologies for assessing and profiling DNA methylation an
histone modifications
- Competitive landscape
Chapter 2 Epigenetics: Central and Essential Role in Differentiation and Disease
- Mechanisms and consequences of epigenetic modifications
- DNA and histone modifications that contribute to epigenetic regulation
- How epigenetic modifications affect gene expression
- Epigenetic aberrations in different diseases: Genes affected
Chapter 3 Epigenetics market landscape
- Epigenetics-based therapeutics
- HDAC inhibitors: Current status and research pipeline
- Emerging market trends in epigenetic therapeutics
- Epigenetics market landscape worldwide market survey: Data and analyses
- Qualitative market trends
- Quantitative market trends
Chapter 4 Pluripotency, hESCs, Reprogramming, iPSCs: Technical and Market Landscape
- iPSCs: Potential applications and limitations
- Small molecules and factors used in cellular reprogramming
- Methods of factor delivery for cellular reprogramming
- Pluripotency, hESCs, iPSCs market landscape worldwide market survey: Data
and analyses
- Qualitative market trends
- Quantitative market trends
- Usage pattern of various hESC lines from worldwide sources
Appendix 1. Research Methodology
Appendix 2. Global hESC Regulatory Landscape
Appendix 3. Pipeline of Epigenetics Therapeutics
|
